Skip to main content
. 2022 Jul 5;10(7):1597. doi: 10.3390/biomedicines10071597

Figure 4.

Figure 4

The structure of trastuzumab deruxtecan (Enhertu®), with a drug-to-antibody ratio (DAR) of 7.7.